U-Chart Analysis:Sumitomo Pharma Co., Ltd.:4506

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Sumitomo Pharma Co., Ltd. Go to web site 4506 Medicals 東証プライム March 1, 2000 1949.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Sumitomo Pharma Co., Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Sumitomo Pharma Co., Ltd. Balance Sheet 2025年3月期 Sumitomo Pharma Co., Ltd. Balance Sheet 2024年3月期 Sumitomo Pharma Co., Ltd. Balance Sheet 2023年3月期 Sumitomo Pharma Co., Ltd. Balance Sheet 2022年3月期 Sumitomo Pharma Co., Ltd. Balance Sheet 2021年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Cash and Cash Equivalents 23,116 29,047 143,478 202,984 193,698
Other Current AssetsHelp 230,052 240,522 238,382 296,537 266,097
Tangible Fixed AssetsHelp 46,648 57,895 58,909 64,091 64,966
Intangible Fixed AssetHelp 172,509 195,652 329,314 398,692 383,406
Investments and OthersHelp 72,873 184,607 155,244 150,559 223,468
Total AssetsHelp 742,604 907,506 1,134,742 1,308,007 1,308,127
Total Current LiabilitiesHelp 314,143 618,076 483,865 456,156 463,698
Total Long-term LiabilitiesHelp 258,982 133,367 244,128 243,963 263,859
Shareholder's EquityHelp 169,479 156,063 406,749 607,888 580,570
Total LiabilitiesHelp 742,604 907,506 1,134,742 1,308,007 1,308,127

Sumitomo Pharma Co., Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Sumitomo Pharma Co., Ltd. Profit and Loss Account 2025年3月期 Sumitomo Pharma Co., Ltd. Profit and Loss Account 2024年3月期 Sumitomo Pharma Co., Ltd. Profit and Loss Account 2023年3月期 Sumitomo Pharma Co., Ltd. Profit and Loss Account 2022年3月期 Sumitomo Pharma Co., Ltd. Profit and Loss Account 2021年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Amount of Sales 398,832 314,558 555,544 560,035 515,952
Total Sales 398,832 314,558 555,544 560,035 515,952
Cost of SalesHelp 153,437 126,528 178,494 157,116 137,645
Other Costs and RevenueHelp 221,761 502,999 451,562 346,506 322,088
Total CostsHelp 375,198 629,527 630,056 503,622 459,733
Net RevenueHelp 245,395 188,030 377,050 402,919 378,307
Earnings Before TaxHelp 17,611 -323,114 -47,920 82,961 77,851
Net IncomeHelp 23,634 -314,969 -74,512 56,413 56,219
Net Income 23,634 -314,969 -74,512 56,413 56,219

Sumitomo Pharma Co., Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Sumitomo Pharma Co., Ltd. Cash Flow Statement 2025年3月期 Sumitomo Pharma Co., Ltd. Cash Flow Statement 2024年3月期 Sumitomo Pharma Co., Ltd. Cash Flow Statement 2023年3月期 Sumitomo Pharma Co., Ltd. Cash Flow Statement 2022年3月期 Sumitomo Pharma Co., Ltd. Cash Flow Statement 2021年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Operating Cash Flow(OFC)Help 3,328 -240,758 10,802 31,239 135,601
Investing Cash Flow(ICF)Help 99,754 33,036 52,419 -18,278 8,875
Financing Cash FlowHelp -108,836 77,851 -146,817 -21,426 -57,215
Exchange Difference of Cash and Cash EquivalentsHelp -177 15,440 24,090 17,751 4,729
Net Increase and Decrease in Cash and Cash Equivalentsn -5,931 -114,431 -59,506 9,286 91,990

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Sumitomo Pharma Co., Ltd.

Company where related level is highHelp

Otsuka Holdings Co.,Ltd.
GNI Group Ltd.
CHUKYOIYAKUHIN CO.,LTD.
Cyfuse Biomedical K.K.
D.Western Therapeutics Institute, Inc.
RIBOMIC Inc.
Mochida Pharmaceutical Co.,Ltd.
TAIKO PHARMACEUTICAL CO.,LTD.
SymBio Pharmaceuticals Limited
Noile-Immune Biotech Inc.